In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Valve for Life - Portugal

Valve for Life Initiative welcomes Portugal on board

After a successful launch of the Valve for Life Initiative in 2015 in Poland and France, it was decided to include a third country in the initiative.
Portugal joined the initiative in January 2017 and was selected on the basis of a significant underuse of TAVI procedures when compared to other European countries and a very committed and well-organized cardiology leadership in Portugal who could address the conduct of the initiative

Country situation - challenges

Significant underuse of TAVI procedures when compared to other European countries and a very clear and determined cardiology leadership in Portugal that can address the conduct of the Initiative was one of the reasons for Portugal to be selected as a third pilot country to join the Initiative. The perspectives to improve valvular heart disease treatment, to promote the use of the technology in Portugal, and to increase the number of TAVI and mitral procedures thanks to the efforts of the Initiative seems promising and the perspectives to duplicate the success of the other participant countries realistic.

Before fully immersing into the Valve for Life Initiative, Portugal committed to providing a multi-dimensional GAP analysis outlining the current situation around TAVI procedures in Portugal and the reasons behind the current low use of TAVI.

Expectations and actions

Valve for Life Portugal's main goal was set to raise the number of TAVI from 40 in January 2017, achieving 120 percutaneous valvular procedures per million habitants in 5 years (by the end of 2021).
For that, strategic objectives and actions were grouped as follow:

1. Raise awareness at patient and health professionals level about valvular disease

Actions for this strategic objective include the creation and maintenance of a national education campaign (“Corações de Amanhã”), media relations (presence in national TV programs, written press, and social media), a market study on disease awareness, and the creation of a valvular patient national database.

2. Increase diagnosis on valvular disease, facilitate access to Heart Team programmes, and promote professional training in structural heart interventions.

Actions for this strategic objective include the presence at educational events with an influential network of primary care practitioners, internal medicine specialists, and clinical cardiologists, the organization of an annual valvular interventions national meeting, the education and support of new heart teams and mitral centres, and the elaboration of a national position paper on the proper diagnosis and treatment of mitral regurgitation

3. Ensure intra-structural funding and access to treatment technology

Actions for this strategic objective include the VaP Registry automatic update, the publication of national TAVI and Mitral registry results, health minister sensitisation, and the realization of an economic impact study on SHD/TAVI in Portugal.


2019 final results show a 73,9% increase in total valvular procedures per million inhabitants, and an 80% increase in TAVI procedures per million inhabitants, when compared with January 2017 numbers.

 TAVI per million population

 Valvular Procedures per million population


Country Champions:

Prof. Lino Patrício
Dr. Rui Campante Teles

Last update: December 2020